MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
2.570
0.00 (0.00%)
Sep 18, 2024, 4:00 PM EDT - Market closed
MDxHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 80.74 | 70.19 | 37.05 | 22.24 | 18.46 | 11.79 | Upgrade
|
| Revenue Growth (YoY) | 45.51% | 89.43% | 66.62% | 20.47% | 56.64% | -58.50% | Upgrade
|
| Cost of Revenue | 30.17 | 26.26 | 17.84 | 11.68 | 10.42 | 11.76 | Upgrade
|
| Gross Profit | 50.57 | 43.93 | 19.22 | 10.56 | 8.04 | 0.03 | Upgrade
|
| Selling, General & Admin | 62.52 | 59.93 | 45.31 | 31.37 | 30.74 | 33.01 | Upgrade
|
| Research & Development | 8.45 | 6.38 | 5.45 | 5.59 | 4.27 | 3.85 | Upgrade
|
| Other Operating Expenses | -0.84 | -0.13 | 0.07 | -0.12 | -0.12 | 0.05 | Upgrade
|
| Operating Expenses | 74.63 | 70.67 | 54.01 | 38.45 | 34.89 | 36.91 | Upgrade
|
| Operating Income | -24.06 | -26.74 | -34.79 | -27.88 | -26.85 | -36.88 | Upgrade
|
| Interest Expense | -6.08 | -5.58 | -2.64 | -1.88 | -1.35 | -0.32 | Upgrade
|
| Interest & Investment Income | 1.13 | 1.09 | 0.13 | 0.01 | 0 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.47 | -2.12 | 0.01 | -0.1 | -0.19 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | -30.47 | -33.36 | -37.29 | -29.85 | -28.39 | -37.28 | Upgrade
|
| Merger & Restructuring Charges | - | - | -3.7 | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -1.15 | Upgrade
|
| Asset Writedown | - | - | -0.04 | - | -0.27 | -5.15 | Upgrade
|
| Other Unusual Items | -10.33 | -9.74 | -3.01 | 0.85 | - | -0.1 | Upgrade
|
| Pretax Income | -40.8 | -43.1 | -44.04 | -29 | -28.66 | -43.68 | Upgrade
|
| Income Tax Expense | 0 | 0 | - | - | - | -0.58 | Upgrade
|
| Net Income | -40.8 | -43.1 | -44.04 | -29 | -28.66 | -43.1 | Upgrade
|
| Net Income to Common | -40.8 | -43.1 | -44.04 | -29 | -28.66 | -43.1 | Upgrade
|
| Shares Outstanding (Basic) | 27 | 26 | 16 | 12 | 8 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 26 | 16 | 12 | 8 | 6 | Upgrade
|
| Shares Change (YoY) | 32.87% | 63.31% | 30.12% | 46.56% | 32.95% | 8.62% | Upgrade
|
| EPS (Basic) | -1.49 | -1.66 | -2.78 | -2.38 | -3.44 | -6.89 | Upgrade
|
| EPS (Diluted) | -1.49 | -1.66 | -2.78 | -2.38 | -3.44 | -6.89 | Upgrade
|
| Free Cash Flow | -22.81 | -24.24 | -36.91 | -23.44 | -20.78 | -22.36 | Upgrade
|
| Free Cash Flow Per Share | -0.83 | -0.94 | -2.33 | -1.92 | -2.50 | -3.57 | Upgrade
|
| Gross Margin | 62.64% | 62.58% | 51.87% | 47.50% | 43.58% | 0.25% | Upgrade
|
| Operating Margin | -29.80% | -38.09% | -93.88% | -125.37% | -145.45% | -312.91% | Upgrade
|
| Profit Margin | -50.54% | -61.40% | -118.86% | -130.41% | -155.27% | -365.72% | Upgrade
|
| Free Cash Flow Margin | -28.25% | -34.54% | -99.60% | -105.42% | -112.57% | -189.75% | Upgrade
|
| EBITDA | -18.62 | -21.59 | -31.89 | -24.85 | -24.29 | -35.88 | Upgrade
|
| EBITDA Margin | -23.06% | -30.76% | -86.06% | -111.72% | -131.58% | - | Upgrade
|
| D&A For EBITDA | 5.44 | 5.15 | 2.9 | 3.04 | 2.56 | 1 | Upgrade
|
| EBIT | -24.06 | -26.74 | -34.79 | -27.88 | -26.85 | -36.88 | Upgrade
|
| EBIT Margin | -29.80% | -38.09% | -93.88% | -125.37% | -145.45% | - | Upgrade
|
| Revenue as Reported | 80.74 | 70.19 | 37.05 | 22.24 | 18.46 | 11.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.